Ganeden secures patent protection for ultra-stable Bacillus coagulans probiotics in coffee, tea, cereal
Ganeden Biotech - the Ohio-based company behind ultra-resilient probiotic BC30 (Bacillus coagulans GBI-30, 6086) - has announced the issuance of a US patent covering the use of all Bacillus coagulans strains (including BC30) in coffee, tea and cereal.